Auxly Cannabis Group Inc (TSE:XLY)
TSX:XLY
Want to see TSE:XLY full AI Analyst Report?
XLY Stock Chart & Stats
C$0.14
>-C$0.01(-10.00%)
At close: 4:00 PM EST
C$0.14
>-C$0.01(-10.00%)
Day’s Range― - ―
52-Week RangeC$0.08 - C$0.19
Previous CloseN/A
Volume80.76K
Average Volume (3M)979.68K
Market Cap
C$224.50M
Enterprise ValueC$223.34M
Total Cash (Recent Filing)C$43.06M
Total Debt (Recent Filing)C$55.78M
Price to Earnings (P/E)6.6
Beta1.00
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding1,403,150,400
10 Day Avg. Volume1,296,089
30 Day Avg. Volume979,678
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)1.09
Price to Sales (P/S)1.27
P/FCF Ratio8.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.25Price Target Upside78.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.01
Revenue Forecast (FY)C$162.60M
Bulls Say, Bears Say
Bulls Say
Revenue Growth & ScaleSustained revenue expansion to C$158.6M (TTM) signals improved market penetration in Canada's adult-use channel. This scale supports better fixed-cost absorption, stronger negotiating leverage with provincial buyers, and a platform to expand higher-margin derivatives, helping durable top-line resilience.
Profitability RecoveryTransition from deep losses to positive operating and net profits establishes a baseline of earnings power. Durable profitability enables reinvestment in product development, reduces dilution or restructuring needs, and provides a buffer to withstand regulatory or pricing headwinds over the medium term.
Improved Balance Sheet & Cash FlowMaterial reduction in leverage combined with consistently positive operating and free cash flow improves financial flexibility. That shift lowers refinancing risk, increases capacity to fund growth or absorb shocks, and supports sustained investment in manufacturing and brand distribution channels.
Bears Say
Margin CompressionSigns of margin erosion in the TTM period versus 2025 suggest intensifying pricing or mix challenges. If structural, weaker margins can erode the profitability recovery, reduce free cash generation, and limit the company's ability to invest in higher-margin product lines or sustain marketing and distribution spend.
Short Track Record Of Cash StrengthPositive cash generation is a recent phenomenon following multi-year cash deficits. A short track record makes durability uncertain across cycles; a single-year improvement may not reflect structural cash conversion, leaving the company vulnerable if volumes or realizations weaken.
Legacy High LeverageAlthough leverage has declined, the recent history of materially elevated debt and negative returns implies lingering refinancing sensitivity and potential higher cost of capital. In adverse conditions, past leverage could constrain capital allocation and limit strategic optionality.
Auxly Cannabis Group News
XLY FAQ
What was Auxly Cannabis Group Inc’s price range in the past 12 months?
Auxly Cannabis Group Inc lowest stock price was C$0.07 and its highest was C$0.19 in the past 12 months.
What is Auxly Cannabis Group Inc’s market cap?
Auxly Cannabis Group Inc’s market cap is C$224.50M.
When is Auxly Cannabis Group Inc’s upcoming earnings report date?
Auxly Cannabis Group Inc’s upcoming earnings report date is Aug 17, 2026 which is in 70 days.
How were Auxly Cannabis Group Inc’s earnings last quarter?
Auxly Cannabis Group Inc released its earnings results on May 14, 2026. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.
Is Auxly Cannabis Group Inc overvalued?
According to Wall Street analysts Auxly Cannabis Group Inc’s price is currently Undervalued.
Does Auxly Cannabis Group Inc pay dividends?
Auxly Cannabis Group Inc does not currently pay dividends.
What is Auxly Cannabis Group Inc’s EPS estimate?
Auxly Cannabis Group Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Auxly Cannabis Group Inc have?
Auxly Cannabis Group Inc has 1,403,150,400 shares outstanding.
What happened to Auxly Cannabis Group Inc’s price movement after its last earnings report?
Auxly Cannabis Group Inc reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went up 7.143%.
Which hedge fund is a major shareholder of Auxly Cannabis Group Inc?
Currently, no hedge funds are holding shares in TSE:XLY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Auxly Cannabis Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$0.25 (78.57% Upside)
C$0.25 (78.57% Upside)
Insider Transactions
Bought Shares
Worth C$100.4K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
300.00%
12-Months-Change
Fundamentals
Return on Equity
19.79%
Trailing 12-Months
Asset Growth
8.92%
Trailing 12-Months
Company Description
Auxly Cannabis Group Inc
Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. The company focuses on developing, manufacturing, and distributing cannabis products for wellness and recreational consumers. It offers cannabis products under various forms, including vape catridges, dried flower, concentrates, chocolates, soft chews, oil drops, capsules, topicals, and hard candy under the brands KOLAB PROJECT, Dosecann, BACK FORTY, and Foray. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Toronto, Canada.
XLY Earnings Call
Q1 2026
0:00 / 0:00
XLY Stock 12 Month Forecast
Average Price Target
C$0.25
▲(78.57% Upside)
Technical Analysis
Canopy Growth
―
Organigram Global
―
Aurora Cannabis
―
Cronos Group
―
Trulieve Cannabis
―
Options Prices
Currently, No data available
---